Medical Imaging Key Laboratory of Sichuan Province, Department of Radiology, Affiliated Hospital of North Sichuan Medical College, 1 South Maoyuan Street, Nanchong, 637001, China.
Institute of Burn Research Southwest Hospital State Key Lab of Trauma Burn and Combined Injury Chongqing Key Laboratory for Disease Proteomics Army Medical University, Chongqing, 400038, China.
J Nanobiotechnology. 2023 Nov 23;21(1):443. doi: 10.1186/s12951-023-02200-x.
Acute pancreatitis (AP) is a common and life-threatening digestive disorder. However, its diagnosis and treatment are still impeded by our limited understanding of its etiology, pathogenesis, and clinical manifestations, as well as by the available detection methods. Fortunately, the progress of microenvironment-targeted nanoplatforms has shown their remarkable potential to change the status quo. The pancreatic inflammatory microenvironment is typically characterized by low pH, abundant reactive oxygen species (ROS) and enzymes, overproduction of inflammatory cells, and hypoxia, which exacerbate the pathological development of AP but also provide potential targeting sites for nanoagents to achieve early diagnosis and treatment. This review elaborates the various potential targets of the inflammatory microenvironment of AP and summarizes in detail the prospects for the development and application of functional nanomaterials for specific targets. Additionally, it presents the challenges and future trends to develop multifunctional targeted nanomaterials for the early diagnosis and effective treatment of AP, providing a valuable reference for future research.
急性胰腺炎(AP)是一种常见且危及生命的消化系统疾病。然而,由于我们对其病因、发病机制和临床表现的认识有限,以及现有的检测方法,其诊断和治疗仍然受到阻碍。幸运的是,基于微环境的靶向纳米平台的进展表明,它们具有改变现状的巨大潜力。胰腺炎症微环境通常具有低 pH 值、丰富的活性氧(ROS)和酶、炎症细胞过度产生以及缺氧等特点,这些特点加剧了 AP 的病理发展,但也为纳米制剂提供了潜在的靶向部位,以实现早期诊断和治疗。本综述详细阐述了 AP 炎症微环境的各种潜在靶点,并详细总结了针对特定靶点的功能性纳米材料的开发和应用前景。此外,还提出了开发用于 AP 的早期诊断和有效治疗的多功能靶向纳米材料所面临的挑战和未来趋势,为未来的研究提供了有价值的参考。
J Nanobiotechnology. 2023-11-23
Front Bioeng Biotechnol. 2023-1-10
Molecules. 2022-10-25
Nanoscale Adv. 2022-3-19
Med Sci Monit. 2009-7
J Transl Med. 2022-5-4
World J Gastroenterol. 2010-6-21
Hereditas. 2025-5-31
J Nanobiotechnology. 2024-5-25
Mol Biotechnol. 2025-4
World J Gastroenterol. 2024-2-7
J Nanobiotechnology. 2024-1-23
Semin Cancer Biol. 2023-2
Nat Commun. 2022-12-26
Adv Drug Deliv Rev. 2023-1
Biomaterials. 2022-11